The Future of Autoimmune Research with Victoria Shanmugam, Director of the Office of Autoimmune Disease Research (Ep 089)

Episode 89: The Future of Autoimmune Research with Victoria Shanmugam, Director of the Office of Autoimmune Disease ResearchAutoimmune disease affects an estimated 50 million Americans, yet for decades these conditions have often received less attention, coordination, and funding than other major chronic diseases.That landscape is beginning to change.In this episode of the Autoimmune Wellness Podcast, Mickey Trescott is joined by Dr. Victoria Shanmugam, rheumatologist, physician-scientist, and Director of the Office of Autoimmune Disease Research (OADR) at the National Institutes of Health. Created by Congress in 2023, the OADR was established to coordinate autoimmune disease research across the NIH and help accelerate progress in understanding, treating, preventing, and ultimately curing autoimmune diseases.Together, Mickey and Dr. Shanmugam discuss why the office was created, how autoimmune research is evolving, and the most promising areas of innovation currently underway. They explore everything from environmental triggers and large-scale data platforms to early disease detection, CAR-T therapies, and the future of personalized autoimmune medicine.This conversation offers a hopeful and practical look at where autoimmune research is headed—and what that progress could mean for patients over the next decade.In this episode, you'll learn:Why the Office of Autoimmune Disease Research was created and what its mission isHow autoimmune diseases intersect with every organ system and NIH research instituteWhat the first NIH-wide Strategic Plan for Autoimmune Disease Research includesWhy studying multiple autoimmune diseases together may accelerate discoveriesHow environmental exposures may influence autoimmune disease risk and progressionThe role of large-scale collaborations and data-sharing platforms in researchWhy early detection and preclinical autoimmune disease are major areas of focusHow Type 1 diabetes research is shaping new approaches to preventionWhat CAR-T therapies and other immune-targeted treatments may offer in the futureWhy patient participation and advocacy remain essential to research progressWhat researchers hope to achieve over the next five to ten years in autoimmune medicineResources:Office of Autoimmune Disease Research (OADR)NIH-Wide Strategic Plan for Autoimmune Disease ResearchOADR Quarterly Community Updates (Must Attend Live)NOURISH Challenge InitiativeEXACT Plan Network (Environmental Exposures & Autoimmune Disease)Episode Timeline:00:00 – Why autoimmune research is entering a new era01:41 – Introducing Dr. Victoria Shanmugam03:29 – What is the Office of Autoimmune Disease Research?04:58 – Why autoimmune diseases have historically been under-researched07:19 – Goals of the OADR and coordination across NIH09:54 – Studying more than 140 autoimmune diseases together12:00 – The NOURISH challenge and nutrition research initiatives14:07 – Promising areas of autoimmune disease research16:09 – Environmental exposures and the EXACT Plan Network17:28 – Autoimmune Centers of Excellence and cross-disease collaboration18:34 – New clinical trials and prevention-focused research20:02 – Early detection and preclinical autoimmune disease21:18 – Data platforms and large-scale collaboration efforts25:18 – How patients should think about research progress26:32 – What the next 5–10 years may bring28:49 – How patients can stay informed and engaged30:16 – Why patient voices matter in research31:00 – Wrap-up and closing reflections